# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Name change underscores the Company's transition to developing innovative targeted therapies in immunology, immuno-oncolo...
Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value o...
https://clinicaltrials.gov/ct2/show/NCT04994002
Cerecor (NASDAQ:CERC) reported quarterly losses of $(0.18) per share. This is unchanged from the same period last year. The co...
Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization o...
Gainers